Though Investment In TB R&D Increased In 2016, Funding Represents One-Third Of Need, Report Says

Center for Global Health Policy’s “Science Speaks”: TB R&D spending climbs — but not enough
Antigone Barton, senior editor and writer of “Science Speaks,” discusses a Treatment Action Group report that found “[i]nvestment in research and development toward new tuberculosis drugs, diagnostic tests, and preventive measures increased in 2016 for the first time in seven years … [T]he report shows spending from national governments and multilateral organizations drove the increase.” However, the authors of the report note the spending represents only one-third of what advocates say is needed in the TB response (11/8).